PTGS2 and liver cancer: Sangavi and Langeswaran, using in silico approaches [159], investigated the inhibitory effect of natural compounds on liver cancer, targeting cyclooxygenase 2 (COX-2), an enzyme associated with inflammatory and carcinogenic processes (angiogenesis, metastasis, and apoptosis resistance).